Hosted on MSN1d
Moderna stock climbs as HSBC upgrades to Buy on underestimated pipeline potential
Investing.com -- Shares in biotech firm Moderna (NASDAQ:MRNA) rose more than 4% Monday after HSBC raised its rating on ...
Business Insider19h
Berenberg Bank Sticks to Its Hold Rating for Moderna (MRNA)
In addition to Berenberg Bank, Moderna also received a Hold from HSBC’s Yifeng Liu in a report issued yesterday. However, on the same day, Piper Sandler maintained a Buy rating on Moderna ...
Moderna Remains Confident Despite Political Concerns Over Vaccine Safety and HHS Nomination
Last week, some large European and U.S. vaccine maker stocks fell in reaction to Robert F. Kennedy Jr.’s nomination to lead ...
Demystifying Moderna: Insights From 16 Analyst Reviews
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $84.0, a ...
bovnews3d
What’s Causing Moderna Inc (MRNA) Stock’s -70.03% Drop Over the Last Six Months?
On Thursday, Moderna Inc (MRNA) stock saw a decline, ending the day at $39.77 which represents a decrease of $-2.37 or -5.62% from the prior close of $42.14. The stock opened at $42.05 and touched a ...
Seeking Alpha28d
Moderna: Assessing The Impact Of GSK's Patent Lawsuit
This time, we have GSK (GSK) "GSK" filing a lawsuit against Moderna (NASDAQ:MRNA) accusing them of patent infringement on their lipid nanoparticle (LNP) technology, which is used in mRNA ...
Moderna’s Strategic Shift and Financial Outlook Leads to Sell Rating and Lowered Price Target
Leerink Partners analyst Mani Foroohar has reiterated their bearish stance on MRNA stock, giving a Sell rating on November 14.Don't Miss our ...
bovnews7d
Moderna Inc (MRNA) Posted -43.84% Profit Margin Last Year—Can It Hold Up?
On Friday, Moderna Inc (MRNA) stock saw a decline, ending the day at $46.83 which represents a decrease of $-3.45 or -6.86% from the prior close of $50.28. The stock opened at $50.42 and touched a low ...